You have free access to this content

British Journal of Clinical Pharmacology

Cover image for British Journal of Clinical Pharmacology

January 2002

Volume 53, Issue 1

Pages 1–109

  1. Editorial

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      The Journal moves online for submission and peer review (pages 1–2)

      M. S. Lennard, J. M. Ritter, E. J. Begg and G. T. Tucker

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.001573.x

      • image
  2. Review series

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      Pharmacogenetics of asthma (pages 3–15)

      A. Fenech and I. P. Hall

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01509.x

      • image
      • image
  3. Pharmacokinetics

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants (pages 17–22)

      Kenneth F. Ilett, Judith H. Kristensen, L. Peter Hackett, Michael Paech, Rolland Kohan and Jonathan Rampono

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01518.x

      • image
    2. You have free access to this content
      The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria (pages 23–30)

      Kenneth F. Ilett, Kevin T. Batty, Shane M. Powell, Tran Quang Binh, Le Thi Anh Thu, Hoang Lan Phuong, Nguyen Canh Hung and Timothy M. E. Davis

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01519.x

      • image
      • image
      • image
  4. Pharmacodynamics

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      The impact of antihypertensive drug groups on urinary albumin excretion in a non-diabetic population (pages 31–36)

      Taco B. M. Monster, Wilbert M. T. Janssen, Paul E. De Jong, Lolkje T. W. De Jong-van den Berg and for the PREVEND Study Group

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01503.x

      • image
    2. You have free access to this content
    3. You have free access to this content
  5. Pharmacokinetics/pharmacodynamics

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions (pages 49–57)

      B. R. Ogutu, C. R. J. C. Newton, J. Crawley, S. N. Muchohi, G. O. Otieno, G. Edwards, K. Marsh and G. O. Kokwaro

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01529.x

      • image
      • image
      • image
    2. You have free access to this content
      Pharmacodynamic effect of continuous vs intermittent dosing of dofetilide on QT interval (pages 59–65)

      Michael J. Allen, Stuart D. Oliver, Margaret W. Newgreen and Donald J. Nichols

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01511.x

      • image
      • image
  6. Drug disposition

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      The effects of an oral contraceptive containing ethinyloestradiol and norgestrel on CYP3A activity (pages 67–74)

      Donna J. Belle, John T. Callaghan, J. Christopher Gorski, Juan F. Maya, Omiema Mousa, Steven A. Wrighton and Stephen D. Hall

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01521.x

      • image
      • image
      • image
    2. You have free access to this content
      St John's Wort increases expression of P-glycoprotein: Implications for drug interactions (pages 75–82)

      M. Hennessy, D. Kelleher, J. P. Spiers, M. Barry, P. Kavanagh, D. Back, F. Mulcahy and J. Feely

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01516.x

      • image
      • image
      • image
  7. Drug interaction

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide (pages 83–91)

      Huw D. Thomas, David J. Porter, Imke Bartelink, Joy R. Nobbs, Michael Cole, Suzie Elliott, David R. Newell, A. Hilary Calvert, Martin Highley and Alan V. Boddy

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01513.x

      • image
      • image
      • image
      • image
  8. Therapeutics

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
  9. Pharmacovigilance

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      Statins and the risk of idiopathic venous thromboembolism (pages 101–105)

      Chen-Chang Yang, Susan S. Jick and Hershel Jick

      Version of Record online: 11 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01523.x

  10. Short report

    1. Top of page
    2. Editorial
    3. Review series
    4. Pharmacokinetics
    5. Pharmacodynamics
    6. Pharmacokinetics/pharmacodynamics
    7. Drug disposition
    8. Drug interaction
    9. Therapeutics
    10. Pharmacovigilance
    11. Short report
    1. You have free access to this content
      Comparison of the clinical efficacy of standard and mucoadhesive-based nasal decongestants (pages 107–109)

      Christo T. Tzachev, Mariana Mandajieva, Evgeniy H. Minkov and Todor A. Popov

      Version of Record online: 18 JAN 2002 | DOI: 10.1046/j.0306-5251.2001.01525.x

      • image
      • image

SEARCH

SEARCH BY CITATION